Trigyn Technologies passes all resolutions at 40th AGM

scanx
Reviewed by
Jubin VScanX News Team
Key Highlights
  • All three resolutions at Trigyn Technologies' 40th AGM were passed with requisite majority
  • Promoter group voted 100% of their 13.7 million shares, while public non-institutions voted <0.23%
  • Re-appointment of Dr. P. Raja Mohan Rao saw 756 dissenting votes from public non-institutions
  • Appointment of Mr. Narendra Bhandari as Independent Director approved with 99.99% support
powered bylight_fuzz_icon
52391766

*this image is generated using AI for illustrative purposes only.

Trigyn Technologies Limited concluded its 40th Annual General Meeting on September 30, 2026, with all proposed resolutions approved by shareholders. The meeting was conducted via video conferencing and other audio-visual means.

The company submitted the voting results and the scrutinizer's report to stock exchanges on October 1, 2026. A total of 35 shareholders attended the meeting through the digital platform, comprising one promoter representative and 34 public shareholders. Remote e-voting was also available for those unable to attend live.

Key resolutions approved

Shareholders voted on three primary agenda items. The first resolution involved the adoption of audited financial statements for the fiscal year ended March 31, 2026, along with the Board of Directors' and Auditors' reports. This resolution received overwhelming support, with 99.9999% of votes cast in favor.

The second resolution concerned the re-appointment of Dr. P. Raja Mohan Rao (DIN: 00157346), who retired by rotation and offered himself for re-appointment. This ordinary resolution was passed with 99.9945% of votes in favor. Notably, a small fraction of public non-institutional shareholders voted against this re-appointment, accounting for 1.9549% of their category's votes polled.

The third item was a special resolution for the appointment of Mr. Narendra Bhandari (DIN: 07501370) as an Independent Director, not liable to retire by rotation. This appointment was approved with 99.9949% of votes in favor.

Voting participation details

The voting process was overseen by Anmol Jha & Associates, acting as the scrutinizer. The results highlight a significant disparity in participation between promoter and public shareholders.

Resolution Votes in Favor Votes Against % In Favor
Adoption of Financial Statements 13,770,779 2 99.9999%
Re-appointment of Dr. P. Raja Mohan Rao 13,770,025 756 99.9945%
Appointment of Mr. Narendra Bhandari 13,770,079 702 99.9949%

Promoter and promoter group shareholders held 13,701,877 shares and exercised 100% of their voting rights on all resolutions. In contrast, public institutional shareholders held 56,679 shares but only voted 30,231 shares, representing 53.3372% participation. Public non-institutional shareholders held 17,027,180 shares but voted only 38,673 shares, indicating a low turnout of 0.2271% from this segment.

What the numbers show

A distinct pattern emerges when comparing voting turnout across shareholder categories. While promoters utilized their entire holding of 13.7 million shares for voting, public non-institutional investors participated minimally, casting votes for less than 0.23% of their total holdings. This suggests that the outcome of the AGM was heavily influenced by the promoter block, which constituted the vast majority of votes polled (13,701,877 out of 13,770,781 total votes). The marginal dissenting votes against director appointments originated exclusively from the public non-institutional segment, highlighting a slight divergence in sentiment among retail investors despite the overall consensus.

Historical Stock Returns for Trigyn Technologies

1 Day5 Days1 Month6 Months1 Year5 Years
-2.64%-7.91%-17.74%+33.76%-39.81%-52.04%

How will the appointment of Mr. Narendra Bhandari as an Independent Director influence Trigyn Technologies' strategic direction and governance standards in the coming fiscal year?

What measures might the company implement to address the extremely low voting participation rate of public non-institutional shareholders in future annual general meetings?

Will the slight dissenting votes from retail investors regarding Dr. P. Raja Mohan Rao's re-appointment signal broader governance concerns that could impact the company's stock valuation?

Trigyn Technologies schedules 40th AGM for September 30, 2026

scanx
Reviewed by
Shriram SScanX News Team
Key Highlights
  • Trigyn Technologies holds its 40th AGM on September 30, 2026
  • Remote e-voting runs from September 27 to September 29, 2026
  • Shareholding cut-off date is set for September 19, 2026
  • Meeting conducted via video conferencing or OAVM
powered bylight_fuzz_icon
50149425

*this image is generated using AI for illustrative purposes only.

Trigyn Technologies has scheduled its 40th Annual General Meeting for Wednesday, September 30, 2026, at 3:30 pm. The meeting will be conducted through Video Conferencing or Other Audio-Visual Means, with the company’s registered office serving as the deemed venue.

The company confirmed the completion of dispatching notices for the AGM on September 7, 2026. Electronic copies of the notice and the annual report for FY26 were sent via email on Saturday, September 5, 2026, to members with registered email IDs. Physical letters containing weblinks were dispatched via post on the same date for shareholders without registered emails.

Voting Schedule

Members holding shares as on the cut-off date of Saturday, September 19, 2026, are eligible to vote electronically. The remote e-voting facility will be available through the National Securities Depository Limited platform.

Event Date & Time (IST)
Cut-off Date September 19, 2026
Remote E-voting Opens September 27, 2026 at 9:00 am
Remote E-voting Closes September 29, 2026 at 5:00 pm
AGM Date & Time September 30, 2026 at 3:30 pm

The company has appointed contact persons to address grievances related to electronic voting, as disclosed in the public notice published in Business Standard and Mumbai Mitra.

Historical Stock Returns for Trigyn Technologies

1 Day5 Days1 Month6 Months1 Year5 Years
-2.64%-7.91%-17.74%+33.76%-39.81%-52.04%

What specific resolutions or strategic initiatives are expected to be tabled for shareholder approval at the upcoming AGM?

How might the voting outcomes on key proposals influence Trigyn Technologies' operational direction or capital allocation in FY27?

Are there any anticipated changes to the board of directors or management team that shareholders should monitor during this meeting?

More News on Trigyn Technologies

1 Year Returns:-39.81%